全国性低剂量计算机断层扫描肺癌筛查:HUNCHEST筛查项目的实施与初步结果
HUNCHEST试点项目前瞻性纳入1890名参与者行低剂量CT肺癌筛查,间隔1年。基线阴性、不确定、阳性结果分别占81.2%、15.1%、3.7%;第一轮筛查中1.2%(n=23)发现恶性病变,共1.5%(n=29)诊断为肺癌,阳性预测值31.6%,86.2%的肺癌为早期。
要点
- 阳性结节标准为非钙化结节体积>500 mm3和/或体积倍增时间<400天。
- 基线筛查阴性81.2%、不确定15.1%、阳性3.7%,阳性预测值31.6%。
- 第一轮筛查1.2%(n=23)发现恶性病变,共1.5%(n=29)诊断肺癌,86.2%为早期。
核心结论
- HUNCHEST试点项目结果提示低剂量CT筛查可能促进肺癌的早期诊断及根治性治疗。
研究设计与样本
- 前瞻性队列研究,共1890名参与者接受低剂量CT筛查,筛查间隔为1年;根据结节体积、生长和体积倍增时间将筛查结果定义为阴性、不确定或阳性;肺癌诊断基于组织学。
关键影像表现/征象
- 非钙化肺结节体积>500 mm3和/或体积倍增时间<400天定义为阳性。
- 基线筛查阴性、不确定、阳性结果分别占81.2%、15.1%、3.7%。
- 当前吸烟者阳性及不确定低剂量CT结果频率显著高于非吸烟者或既往吸烟者(p<0.0001)。
- COPD患者阳性及不确定低剂量CT结果频率显著高于无COPD者(p<0.001)。
诊断标准与关键数值
- 阳性标准:非钙化肺结节体积>500 mm3和/或体积倍增时间<400天。
- 第一轮筛查中1.2%(n=23)的参与者有恶性病变,共1.5%(n=29)诊断为肺癌。
- 阳性检查的总体阳性预测值为31.6%。
- 大多数肺部恶性肿瘤为早期诊断(占所有病例的86.2%)。
临床应用与阅片要点
- 筛查结果按阴性、不确定、阳性三类管理,阳性依据结节体积>500 mm3和/或体积倍增时间<400天判定。
- 当前吸烟者及COPD患者的阳性或不确定低剂量CT结果频率更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Lung cancer (LC) kills more people than any other cancer in Hungary. Hence, there is a clear rationale for considering a national screening program. The HUNCHEST pilot program primarily aimed to investigate the feasibility of a population-based LC screening in Hungary, and determine the incidence and LC probability of solitary pulmonary nodules.
METHODS: A total of 1890 participants were assigned to undergo low-dose CT (LDCT) screening, with intervals of 1 year between procedures. Depending on the volume, growth, and volume doubling time (VDT), screenings were defined as negative, indeterminate, or positive. Non-calcified lung nodules with a volume > 500 mm3 and/or a VDT < 400 days were considered positive. LC diagnosis was based on histology.
RESULTS: At baseline, the percentage of negative, indeterminate, and positive tests was 81.2%, 15.1%, and 3.7%, respectively. The frequency of positive and indeterminate LDCT results was significantly higher in current smokers (vs. non-smokers or former smokers; p < 0.0001) and in individuals with COPD (vs. those without COPD, p < 0.001). In the first screening round, 1.2% (n = 23) of the participants had a malignant lesion, whereas altogether 1.5% (n = 29) of the individuals were diagnosed with LC. The overall positive predictive value of the positive tests was 31.6%. Most lung malignancies were diagnosed at an early stage (86.2% of all cases).
CONCLUSIONS: In terms of key characteristics, our prospective cohort study appears consistent to that of comparable studies. Altogether, the results of the HUNCHEST pilot program suggest that LDCT screening may facilitate early diagnosis and thus curative-intent treatment in LC.
KEY POINTS: • The HUNCHEST pilot study is the first nationwide low-dose CT screening program in Hungary. • In the first screening round, 1.2% of the participants had a malignant lesion, whereas altogether 1.5% of the individuals were diagnosed with lung cancer. • The overall positive predictive value of the positive tests in the HUNCHEST screening program was 31.6%.
引用
- Kerpel-Fronius, Monostori, Kovacs, et al. Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program. Eur Radiol. 2022. PMID: 35247089. doi:10.1007/s00330-022-08589-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。